

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.31932786 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.09957511 |
| 3 | * positive regulation of interferon-alpha production (GO:0032727) | 4.61262126 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.50093373 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.50093373 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.50093373 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.50093373 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.50093373 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 4.50093373 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.41495867 |
| 11 | * regulation of interferon-alpha production (GO:0032647) | 4.40629825 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.32594176 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.32594176 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.18321868 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.15989460 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.10894425 |
| 17 | * regulation of interferon-beta biosynthetic process (GO:0045357) | 4.06087673 |
| 18 | response to type I interferon (GO:0034340) | 4.04292552 |
| 19 | cellular response to type I interferon (GO:0071357) | 4.00118931 |
| 20 | type I interferon signaling pathway (GO:0060337) | 4.00118931 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.96133837 |
| 22 | ribosome assembly (GO:0042255) | 3.88109837 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 3.80915293 |
| 24 | cellular response to interferon-beta (GO:0035458) | 3.65381875 |
| 25 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.57355788 |
| 26 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.56941647 |
| 27 | response to peptidoglycan (GO:0032494) | 3.49875957 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.49745492 |
| 29 | nuclear pore complex assembly (GO:0051292) | 3.45976517 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.45653481 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.44187870 |
| 32 | regulation of B cell differentiation (GO:0045577) | 3.39440676 |
| 33 | defense response to protozoan (GO:0042832) | 3.38495342 |
| 34 | B cell mediated immunity (GO:0019724) | 3.38477882 |
| 35 | negative regulation of cell killing (GO:0031342) | 3.37716469 |
| 36 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.37716469 |
| 37 | * positive regulation of interferon-beta production (GO:0032728) | 3.36734565 |
| 38 | proteasome assembly (GO:0043248) | 3.32374162 |
| 39 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.29906011 |
| 40 | granulocyte activation (GO:0036230) | 3.29823733 |
| 41 | leukocyte aggregation (GO:0070486) | 3.29373372 |
| 42 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.27900284 |
| 43 | B cell receptor signaling pathway (GO:0050853) | 3.27386791 |
| 44 | neutrophil activation (GO:0042119) | 3.25368373 |
| 45 | cellular response to exogenous dsRNA (GO:0071360) | 3.24328944 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.23118434 |
| 47 | hepatocyte apoptotic process (GO:0097284) | 3.21571388 |
| 48 | response to interferon-beta (GO:0035456) | 3.21194337 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.21132758 |
| 50 | natural killer cell mediated immunity (GO:0002228) | 3.18221476 |
| 51 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.18221476 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.17032531 |
| 53 | myeloid dendritic cell activation (GO:0001773) | 3.16565808 |
| 54 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.16065726 |
| 55 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.14764691 |
| 56 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.14090475 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 3.13309283 |
| 58 | response to muramyl dipeptide (GO:0032495) | 3.11578133 |
| 59 | nuclear pore organization (GO:0006999) | 3.11189771 |
| 60 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.10870971 |
| 61 | response to interferon-alpha (GO:0035455) | 3.08419019 |
| 62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.05417568 |
| 63 | myeloid dendritic cell differentiation (GO:0043011) | 3.04696180 |
| 64 | negative regulation of interleukin-17 production (GO:0032700) | 3.04014915 |
| 65 | respiratory burst (GO:0045730) | 3.02121569 |
| 66 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.01419780 |
| 67 | response to protozoan (GO:0001562) | 3.00969406 |
| 68 | response to host immune response (GO:0052572) | 2.99644889 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.99644889 |
| 70 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.96360231 |
| 71 | germinal center formation (GO:0002467) | 2.95668308 |
| 72 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.93906007 |
| 73 | regulation of RIG-I signaling pathway (GO:0039535) | 2.92952833 |
| 74 | positive regulation of interleukin-12 production (GO:0032735) | 2.92227739 |
| 75 | necroptotic process (GO:0070266) | 2.90900470 |
| 76 | negative thymic T cell selection (GO:0045060) | 2.90583282 |
| 77 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.87671052 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.87537384 |
| 79 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.85113082 |
| 80 | T cell migration (GO:0072678) | 2.85043760 |
| 81 | histone mRNA catabolic process (GO:0071044) | 2.84928980 |
| 82 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.83704387 |
| 83 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.82980259 |
| 84 | pore complex assembly (GO:0046931) | 2.82372678 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.82105516 |
| 86 | negative regulation of viral genome replication (GO:0045071) | 2.81082474 |
| 87 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.79538803 |
| 88 | response to host (GO:0075136) | 2.79538803 |
| 89 | response to host defenses (GO:0052200) | 2.79538803 |
| 90 | T-helper 1 type immune response (GO:0042088) | 2.79518436 |
| 91 | positive regulation of humoral immune response (GO:0002922) | 2.78855966 |
| 92 | negative T cell selection (GO:0043383) | 2.78374889 |
| 93 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.77699133 |
| 94 | positive regulation of defense response to virus by host (GO:0002230) | 2.77101771 |
| 95 | positive regulation of macrophage differentiation (GO:0045651) | 2.76779093 |
| 96 | mature B cell differentiation (GO:0002335) | 2.75217953 |
| 97 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.74924778 |
| 98 | leukocyte cell-cell adhesion (GO:0007159) | 2.73388744 |
| 99 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.73049473 |
| 100 | cellular response to zinc ion (GO:0071294) | 2.73038029 |
| 101 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.71329823 |
| 102 | isotype switching (GO:0045190) | 2.71329823 |
| 103 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.71329823 |
| 104 | histamine secretion (GO:0001821) | 2.71205979 |
| 105 | mast cell activation (GO:0045576) | 2.70920234 |
| 106 | regulation of response to interferon-gamma (GO:0060330) | 2.70659055 |
| 107 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70012720 |
| 108 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.68980727 |
| 109 | neutrophil mediated immunity (GO:0002446) | 2.68121580 |
| 110 | cellular response to interferon-gamma (GO:0071346) | 2.67769584 |
| 111 | myeloid leukocyte activation (GO:0002274) | 2.67628701 |
| 112 | positive regulation of response to biotic stimulus (GO:0002833) | 2.67012293 |
| 113 | positive regulation of mast cell activation (GO:0033005) | 2.66895956 |
| 114 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.66809736 |
| 115 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.66578599 |
| 116 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.64165977 |
| 117 | regulation of centriole replication (GO:0046599) | 2.64105570 |
| 118 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.60986671 |
| 119 | DNA double-strand break processing (GO:0000729) | 2.60320582 |
| 120 | dendritic cell differentiation (GO:0097028) | 2.59308786 |
| 121 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.58520833 |
| 122 | protein K6-linked ubiquitination (GO:0085020) | 2.57591325 |
| 123 | detection of molecule of bacterial origin (GO:0032490) | 2.55504961 |
| 124 | negative regulation of interleukin-12 production (GO:0032695) | 2.54340412 |
| 125 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.53731823 |
| 126 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.53731823 |
| 127 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.53731823 |
| 128 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.52121554 |
| 129 | eosinophil chemotaxis (GO:0048245) | 2.51907496 |
| 130 | mitotic G2/M transition checkpoint (GO:0044818) | 2.49602424 |
| 131 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.47972599 |
| 132 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.44329666 |
| 133 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.43520441 |
| 134 | metaphase plate congression (GO:0051310) | 2.43323768 |
| 135 | establishment of chromosome localization (GO:0051303) | 2.43060573 |
| 136 | rRNA methylation (GO:0031167) | 2.41922480 |
| 137 | iron ion import (GO:0097286) | 2.40700970 |
| 138 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.40173573 |
| 139 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.38209384 |
| 140 | negative regulation of ligase activity (GO:0051352) | 2.38209384 |
| 141 | B cell activation involved in immune response (GO:0002312) | 2.34663170 |
| 142 | negative regulation of B cell proliferation (GO:0030889) | 2.34435492 |
| 143 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.33424225 |
| 144 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.31189040 |
| 145 | DNA deamination (GO:0045006) | 2.30869377 |
| 146 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.30657657 |
| 147 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.28195450 |
| 148 | cytidine catabolic process (GO:0006216) | 2.26849924 |
| 149 | cytidine deamination (GO:0009972) | 2.26849924 |
| 150 | cytidine metabolic process (GO:0046087) | 2.26849924 |
| 151 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.26649228 |
| 152 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.26649228 |
| 153 | cellular response to interferon-alpha (GO:0035457) | 2.25615614 |
| 154 | mitotic metaphase plate congression (GO:0007080) | 2.25338179 |
| 155 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.25271083 |
| 156 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.25271083 |
| 157 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.25271083 |
| 158 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.23925459 |
| 159 | cellular response to ethanol (GO:0071361) | 2.21647510 |
| 160 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.21355811 |
| 161 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.19378964 |
| 162 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.18906622 |
| 163 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.18906622 |
| 164 | eosinophil migration (GO:0072677) | 2.18629015 |
| 165 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.17922181 |
| 166 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.17922181 |
| 167 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.16011329 |
| 168 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.14860797 |
| 169 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.13622383 |
| 170 | regulation of viral genome replication (GO:0045069) | 2.13020574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.43789947 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.43088737 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.59408005 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.23308627 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.20449088 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.00155161 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.82046712 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 3.72573212 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.70795042 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.62499861 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.43661015 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.34004868 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.22242697 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.05958920 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.03773044 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.93850067 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.84576119 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.76148893 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.71079031 |
| 20 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.69221991 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.68729528 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.65203305 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39887008 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.27053116 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24814675 |
| 26 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23481122 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19908106 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.16861739 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.09470306 |
| 30 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.07846819 |
| 31 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.07143241 |
| 32 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.05671336 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.04045005 |
| 34 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03941127 |
| 35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.03094803 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.01820379 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.99677096 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.97933836 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93894924 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.92226297 |
| 41 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.90919789 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.85636246 |
| 43 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.82925772 |
| 44 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.81633425 |
| 45 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.75058969 |
| 46 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.71883033 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70842767 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.70629212 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69841605 |
| 50 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.63376278 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.61698975 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60602572 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58915747 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.58191657 |
| 55 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57611707 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.56017607 |
| 57 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.55728115 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.55463401 |
| 59 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.51608073 |
| 60 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.51310577 |
| 61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49708792 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47594315 |
| 63 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46801195 |
| 64 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.45818312 |
| 65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43073218 |
| 66 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.41803569 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40490756 |
| 68 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.40343732 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39774827 |
| 70 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.38239633 |
| 71 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35619316 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33990159 |
| 73 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.33942462 |
| 74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.33093093 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31165773 |
| 76 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.30238673 |
| 77 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.25972949 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24339341 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23490029 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.22582439 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22311699 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21188187 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20171025 |
| 84 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.19790489 |
| 85 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.19635349 |
| 86 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18884167 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17511578 |
| 88 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.17232086 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16607897 |
| 90 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.16464998 |
| 91 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.16258690 |
| 92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15881533 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15608238 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15464678 |
| 95 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13102342 |
| 96 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.13046156 |
| 97 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.12463383 |
| 98 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.11179172 |
| 99 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10697047 |
| 100 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09817736 |
| 101 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09719039 |
| 102 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09588691 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09260321 |
| 104 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08607807 |
| 105 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.08588383 |
| 106 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07423243 |
| 107 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06356239 |
| 108 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05851153 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03663681 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03429980 |
| 111 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02471487 |
| 112 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.01100974 |
| 113 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00778261 |
| 114 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99697354 |
| 115 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.99409042 |
| 116 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97145959 |
| 117 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.96829309 |
| 118 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96171391 |
| 119 | EWS_26573619_Chip-Seq_HEK293_Human | 0.96049107 |
| 120 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95469052 |
| 121 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.95332404 |
| 122 | MAF_26560356_Chip-Seq_TH2_Human | 0.95294114 |
| 123 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92996934 |
| 124 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92995509 |
| 125 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.92346791 |
| 126 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.92230011 |
| 127 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92145444 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92077553 |
| 129 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91220753 |
| 130 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.91205194 |
| 131 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90783884 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.90476908 |
| 133 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.89846839 |
| 134 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89395812 |
| 135 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89125016 |
| 136 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.88704799 |
| 137 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88521890 |
| 138 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87273936 |
| 139 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86692916 |
| 140 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86042711 |
| 141 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.85370533 |
| 142 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84930822 |
| 143 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.80910170 |
| 144 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80228744 |
| 145 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79574832 |
| 146 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.78049407 |
| 147 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77951174 |
| 148 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77009967 |
| 149 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.76456588 |
| 150 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76065507 |
| 151 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76020951 |
| 152 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73897696 |
| 153 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72656797 |
| 154 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.72642360 |
| 155 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.69867604 |
| 156 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.67956252 |
| 157 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.67823236 |
| 158 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.67492021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.33066297 |
| 2 | * MP0009785_altered_susceptibility_to | 3.33759893 |
| 3 | MP0003436_decreased_susceptibility_to | 3.06002368 |
| 4 | MP0005671_abnormal_response_to | 3.00254784 |
| 5 | MP0000685_abnormal_immune_system | 2.90290615 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.86889736 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.79822356 |
| 8 | MP0002419_abnormal_innate_immunity | 2.77534534 |
| 9 | MP0005387_immune_system_phenotype | 2.74792117 |
| 10 | MP0001790_abnormal_immune_system | 2.74792117 |
| 11 | * MP0001800_abnormal_humoral_immune | 2.71000480 |
| 12 | * MP0005025_abnormal_response_to | 2.69220066 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.66375691 |
| 14 | MP0006082_CNS_inflammation | 2.63537898 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.60907293 |
| 16 | * MP0002723_abnormal_immune_serum | 2.52862298 |
| 17 | MP0003724_increased_susceptibility_to | 2.46283975 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.44625507 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.43291156 |
| 20 | * MP0001819_abnormal_immune_cell | 2.36776991 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.34689717 |
| 22 | MP0002006_tumorigenesis | 2.29087271 |
| 23 | MP0000569_abnormal_digit_pigmentation | 2.20239731 |
| 24 | MP0003303_peritoneal_inflammation | 2.17830158 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.15298334 |
| 26 | MP0010094_abnormal_chromosome_stability | 2.02320414 |
| 27 | * MP0002398_abnormal_bone_marrow | 2.02081551 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 2.00377060 |
| 29 | MP0001853_heart_inflammation | 1.91528070 |
| 30 | MP0003195_calcinosis | 1.89527046 |
| 31 | MP0004510_myositis | 1.88214109 |
| 32 | MP0000372_irregular_coat_pigmentation | 1.87086067 |
| 33 | * MP0000716_abnormal_immune_system | 1.86552985 |
| 34 | * MP0004947_skin_inflammation | 1.84500175 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.80456804 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.80440103 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.80440103 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.79001860 |
| 39 | MP0002405_respiratory_system_inflammati | 1.78834439 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.78580360 |
| 41 | MP0004957_abnormal_blastocyst_morpholog | 1.75737787 |
| 42 | * MP0001845_abnormal_inflammatory_respons | 1.74936811 |
| 43 | MP0008007_abnormal_cellular_replicative | 1.72044775 |
| 44 | * MP0000689_abnormal_spleen_morphology | 1.71579334 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.70885674 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.70135107 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.67422600 |
| 48 | MP0002396_abnormal_hematopoietic_system | 1.66350757 |
| 49 | MP0008058_abnormal_DNA_repair | 1.64173412 |
| 50 | * MP0008469_abnormal_protein_level | 1.63332512 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.61587046 |
| 52 | MP0008260_abnormal_autophagy | 1.60785809 |
| 53 | MP0009764_decreased_sensitivity_to | 1.60711536 |
| 54 | * MP0002429_abnormal_blood_cell | 1.58445906 |
| 55 | MP0001873_stomach_inflammation | 1.57718216 |
| 56 | * MP0002722_abnormal_immune_system | 1.57535098 |
| 57 | MP0005451_abnormal_body_composition | 1.54578117 |
| 58 | MP0003221_abnormal_cardiomyocyte_apopto | 1.53799601 |
| 59 | MP0003111_abnormal_nucleus_morphology | 1.53004029 |
| 60 | MP0005075_abnormal_melanosome_morpholog | 1.52251601 |
| 61 | MP0003077_abnormal_cell_cycle | 1.45328643 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.45209309 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.44697203 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.44206711 |
| 65 | MP0002254_reproductive_system_inflammat | 1.41957264 |
| 66 | MP0003693_abnormal_embryo_hatching | 1.40506622 |
| 67 | MP0003786_premature_aging | 1.39535282 |
| 68 | MP0009278_abnormal_bone_marrow | 1.39478137 |
| 69 | MP0010307_abnormal_tumor_latency | 1.38527286 |
| 70 | MP0005310_abnormal_salivary_gland | 1.38324332 |
| 71 | MP0003448_altered_tumor_morphology | 1.36578068 |
| 72 | MP0005408_hypopigmentation | 1.34223424 |
| 73 | MP0003950_abnormal_plasma_membrane | 1.32669019 |
| 74 | MP0000604_amyloidosis | 1.29994557 |
| 75 | MP0009840_abnormal_foam_cell | 1.29358840 |
| 76 | MP0000343_altered_response_to | 1.26071583 |
| 77 | MP0000858_altered_metastatic_potential | 1.21340764 |
| 78 | MP0008877_abnormal_DNA_methylation | 1.20141493 |
| 79 | MP0003075_altered_response_to | 1.15963975 |
| 80 | MP0005174_abnormal_tail_pigmentation | 1.15352550 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.11641306 |
| 82 | MP0010352_gastrointestinal_tract_polyps | 1.09186573 |
| 83 | MP0003866_abnormal_defecation | 1.08046821 |
| 84 | MP0010678_abnormal_skin_adnexa | 1.07724383 |
| 85 | MP0000703_abnormal_thymus_morphology | 1.07705994 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 1.06779140 |
| 87 | MP0009763_increased_sensitivity_to | 1.05637539 |
| 88 | MP0000358_abnormal_cell_content/ | 1.05354187 |
| 89 | MP0005166_decreased_susceptibility_to | 1.03708261 |
| 90 | MP0002138_abnormal_hepatobiliary_system | 1.03683598 |
| 91 | MP0003941_abnormal_skin_development | 1.00381138 |
| 92 | MP0002332_abnormal_exercise_endurance | 0.98954300 |
| 93 | MP0000371_diluted_coat_color | 0.98526333 |
| 94 | MP0003045_fibrosis | 0.97638376 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.97464835 |
| 96 | MP0005360_urolithiasis | 0.96675454 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.94071870 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.91111626 |
| 99 | MP0000490_abnormal_crypts_of | 0.91068947 |
| 100 | MP0008057_abnormal_DNA_replication | 0.90625003 |
| 101 | MP0000609_abnormal_liver_physiology | 0.88855814 |
| 102 | MP0006036_abnormal_mitochondrial_physio | 0.88422829 |
| 103 | * MP0000427_abnormal_hair_cycle | 0.87476048 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.84546010 |
| 105 | MP0005621_abnormal_cell_physiology | 0.82321214 |
| 106 | MP0002019_abnormal_tumor_incidence | 0.81607659 |
| 107 | MP0002933_joint_inflammation | 0.81490025 |
| 108 | MP0004883_abnormal_blood_vessel | 0.81121785 |
| 109 | * MP0001191_abnormal_skin_condition | 0.80271183 |
| 110 | MP0002009_preneoplasia | 0.78721689 |
| 111 | MP0003091_abnormal_cell_migration | 0.78090073 |
| 112 | MP0005384_cellular_phenotype | 0.77936075 |
| 113 | MP0003943_abnormal_hepatobiliary_system | 0.76127765 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 0.75954814 |
| 115 | MP0009697_abnormal_copulation | 0.75296683 |
| 116 | MP0002090_abnormal_vision | 0.74579151 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.74239966 |
| 118 | MP0004147_increased_porphyrin_level | 0.72772282 |
| 119 | * MP0000598_abnormal_liver_morphology | 0.72162992 |
| 120 | MP0000249_abnormal_blood_vessel | 0.71741844 |
| 121 | MP0002139_abnormal_hepatobiliary_system | 0.70114656 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.69075077 |
| 123 | MP0003186_abnormal_redox_activity | 0.68858979 |
| 124 | MP0006054_spinal_hemorrhage | 0.68403656 |
| 125 | MP0005164_abnormal_response_to | 0.65504063 |
| 126 | MP0008873_increased_physiological_sensi | 0.64346291 |
| 127 | MP0010329_abnormal_lipoprotein_level | 0.63876110 |
| 128 | MP0004264_abnormal_extraembryonic_tissu | 0.62896728 |
| 129 | MP0005023_abnormal_wound_healing | 0.62693806 |
| 130 | MP0005390_skeleton_phenotype | 0.61350548 |
| 131 | MP0003828_pulmonary_edema | 0.60600031 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.59838137 |
| 133 | MP0003252_abnormal_bile_duct | 0.59493103 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59301811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.64832084 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.40755475 |
| 3 | Myositis (HP:0100614) | 4.74820055 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.70592146 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.66723150 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.51472373 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.33439971 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.13729695 |
| 9 | Recurrent viral infections (HP:0004429) | 3.87947407 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.61510905 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.58601135 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 3.46755431 |
| 13 | Optic neuritis (HP:0100653) | 3.46193447 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.46193447 |
| 15 | Recurrent skin infections (HP:0001581) | 3.41413906 |
| 16 | Orchitis (HP:0100796) | 3.39104365 |
| 17 | Vasculitis (HP:0002633) | 3.38311294 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.33063121 |
| 19 | Pustule (HP:0200039) | 3.29412886 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.23628816 |
| 21 | Chronic otitis media (HP:0000389) | 3.18021127 |
| 22 | Stomatitis (HP:0010280) | 3.15531409 |
| 23 | Thrombocytosis (HP:0001894) | 3.13834798 |
| 24 | Arterial thrombosis (HP:0004420) | 3.12364223 |
| 25 | Autoimmune hemolytic anemia (HP:0001890) | 3.01419286 |
| 26 | Abnormality of chromosome stability (HP:0003220) | 2.95640103 |
| 27 | Abnormality of T cell number (HP:0011839) | 2.82767755 |
| 28 | Tetraparesis (HP:0002273) | 2.80978658 |
| 29 | Periodontitis (HP:0000704) | 2.80837456 |
| 30 | IgM deficiency (HP:0002850) | 2.79674378 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 2.78004940 |
| 32 | Pulmonary infiltrates (HP:0002113) | 2.76646860 |
| 33 | Gingival bleeding (HP:0000225) | 2.74737091 |
| 34 | Meningitis (HP:0001287) | 2.70080688 |
| 35 | Abnormality of the prostate (HP:0008775) | 2.67627269 |
| 36 | Prostate neoplasm (HP:0100787) | 2.64961704 |
| 37 | Recurrent bronchitis (HP:0002837) | 2.64492972 |
| 38 | Gingivitis (HP:0000230) | 2.64285608 |
| 39 | T lymphocytopenia (HP:0005403) | 2.64052180 |
| 40 | Increased IgM level (HP:0003496) | 2.59844995 |
| 41 | Petechiae (HP:0000967) | 2.59065614 |
| 42 | Leukocytosis (HP:0001974) | 2.58272536 |
| 43 | Papillary thyroid carcinoma (HP:0002895) | 2.56687345 |
| 44 | Osteomyelitis (HP:0002754) | 2.56094590 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.54037708 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.54037708 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 2.53699219 |
| 48 | Thyroiditis (HP:0100646) | 2.53683029 |
| 49 | Epistaxis (HP:0000421) | 2.50927348 |
| 50 | Obstructive lung disease (HP:0006536) | 2.50715400 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.50715400 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.47991218 |
| 53 | Disinhibition (HP:0000734) | 2.47271403 |
| 54 | Abnormality of T cells (HP:0002843) | 2.46691304 |
| 55 | Abnormality of the fingertips (HP:0001211) | 2.46612391 |
| 56 | Cellulitis (HP:0100658) | 2.45665231 |
| 57 | Eosinophilia (HP:0001880) | 2.43167200 |
| 58 | Albinism (HP:0001022) | 2.42948869 |
| 59 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.42055690 |
| 60 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.42055690 |
| 61 | Abnormality of glycolipid metabolism (HP:0010969) | 2.42055690 |
| 62 | Myelodysplasia (HP:0002863) | 2.38659692 |
| 63 | Lymphopenia (HP:0001888) | 2.37494245 |
| 64 | Basal ganglia calcification (HP:0002135) | 2.37214948 |
| 65 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.35342665 |
| 66 | Agnosia (HP:0010524) | 2.35268588 |
| 67 | Chronic diarrhea (HP:0002028) | 2.33722381 |
| 68 | B lymphocytopenia (HP:0010976) | 2.33074036 |
| 69 | Abnormality of B cell number (HP:0010975) | 2.33074036 |
| 70 | Joint swelling (HP:0001386) | 2.30087848 |
| 71 | Hypoplasia of the thymus (HP:0000778) | 2.30082679 |
| 72 | IgA deficiency (HP:0002720) | 2.28612934 |
| 73 | Hemoptysis (HP:0002105) | 2.27962438 |
| 74 | Severe combined immunodeficiency (HP:0004430) | 2.27208283 |
| 75 | Keratoconjunctivitis (HP:0001096) | 2.27036362 |
| 76 | Combined immunodeficiency (HP:0005387) | 2.25487164 |
| 77 | IgG deficiency (HP:0004315) | 2.23348354 |
| 78 | Hematochezia (HP:0002573) | 2.23185349 |
| 79 | Thyroid carcinoma (HP:0002890) | 2.22645496 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 2.22617792 |
| 81 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.22029238 |
| 82 | Abnormality of T cell physiology (HP:0011840) | 2.19859995 |
| 83 | Dyschromatopsia (HP:0007641) | 2.18685710 |
| 84 | Gastrointestinal stroma tumor (HP:0100723) | 2.18643376 |
| 85 | Prolonged bleeding time (HP:0003010) | 2.17907664 |
| 86 | Panhypogammaglobulinemia (HP:0003139) | 2.17861700 |
| 87 | Hypergammaglobulinemia (HP:0010702) | 2.17384236 |
| 88 | Abnormality of eosinophils (HP:0001879) | 2.17182991 |
| 89 | Amaurosis fugax (HP:0100576) | 2.16250261 |
| 90 | Chest pain (HP:0100749) | 2.15995606 |
| 91 | Encephalitis (HP:0002383) | 2.15217859 |
| 92 | Gastrointestinal infarctions (HP:0005244) | 2.14651627 |
| 93 | Granulocytopenia (HP:0001913) | 2.14598680 |
| 94 | Cutaneous melanoma (HP:0012056) | 2.13266678 |
| 95 | Abnormal platelet function (HP:0011869) | 2.11524674 |
| 96 | Impaired platelet aggregation (HP:0003540) | 2.11524674 |
| 97 | Spontaneous hematomas (HP:0007420) | 2.09895110 |
| 98 | Abnormal platelet volume (HP:0011876) | 2.09707013 |
| 99 | Autoamputation (HP:0001218) | 2.09690989 |
| 100 | Abnormality of the preputium (HP:0100587) | 2.09182907 |
| 101 | Upper motor neuron abnormality (HP:0002127) | 2.09090281 |
| 102 | Loss of speech (HP:0002371) | 2.08958496 |
| 103 | Entropion (HP:0000621) | 2.06107609 |
| 104 | Acute hepatic failure (HP:0006554) | 2.05626938 |
| 105 | Urticaria (HP:0001025) | 2.04186016 |
| 106 | Volvulus (HP:0002580) | 2.03236052 |
| 107 | Recurrent pneumonia (HP:0006532) | 2.02516783 |
| 108 | Rhabdomyosarcoma (HP:0002859) | 2.01862114 |
| 109 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.01539845 |
| 110 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.01539845 |
| 111 | Abnormal protein glycosylation (HP:0012346) | 2.01539845 |
| 112 | Abnormal glycosylation (HP:0012345) | 2.01539845 |
| 113 | Anorexia (HP:0002039) | 2.00730722 |
| 114 | Agammaglobulinemia (HP:0004432) | 2.00714830 |
| 115 | Chromsome breakage (HP:0040012) | 1.99831555 |
| 116 | Arthralgia (HP:0002829) | 1.97916746 |
| 117 | Degeneration of anterior horn cells (HP:0002398) | 1.97735708 |
| 118 | Abnormality of the anterior horn cell (HP:0006802) | 1.97735708 |
| 119 | Dysostosis multiplex (HP:0000943) | 1.97544253 |
| 120 | Myocardial infarction (HP:0001658) | 1.97364104 |
| 121 | Freckling (HP:0001480) | 1.94621749 |
| 122 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.94411031 |
| 123 | Acute myeloid leukemia (HP:0004808) | 1.93353531 |
| 124 | Vertebral compression fractures (HP:0002953) | 1.93192288 |
| 125 | Lymphoma (HP:0002665) | 1.92819496 |
| 126 | Abnormal spermatogenesis (HP:0008669) | 1.92680147 |
| 127 | Thrombophlebitis (HP:0004418) | 1.92241922 |
| 128 | Increased mean platelet volume (HP:0011877) | 1.91051905 |
| 129 | Colitis (HP:0002583) | 1.91016745 |
| 130 | Posterior subcapsular cataract (HP:0007787) | 1.88145490 |
| 131 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.85590804 |
| 132 | Breast carcinoma (HP:0003002) | 1.84983542 |
| 133 | Hypobetalipoproteinemia (HP:0003563) | 1.84051770 |
| 134 | Gangrene (HP:0100758) | 1.82191129 |
| 135 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.81760168 |
| 136 | Prominent nose (HP:0000448) | 1.80866548 |
| 137 | Increased hepatocellular lipid droplets (HP:0006565) | 1.80864464 |
| 138 | Progressive external ophthalmoplegia (HP:0000590) | 1.78683657 |
| 139 | Clubbing of toes (HP:0100760) | 1.78216625 |
| 140 | Deep philtrum (HP:0002002) | 1.77172580 |
| 141 | Fatigue (HP:0012378) | 1.74638185 |
| 142 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.74265473 |
| 143 | Hypochromic microcytic anemia (HP:0004840) | 1.73699916 |
| 144 | Osteolytic defects of the hand bones (HP:0009699) | 1.73328024 |
| 145 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.73328024 |
| 146 | Biliary tract neoplasm (HP:0100574) | 1.73056054 |
| 147 | Lipid accumulation in hepatocytes (HP:0006561) | 1.73007803 |
| 148 | Ascites (HP:0001541) | 1.72947092 |
| 149 | Progressive neurologic deterioration (HP:0002344) | 1.72825954 |
| 150 | Micronodular cirrhosis (HP:0001413) | 1.72132877 |
| 151 | Alveolar cell carcinoma (HP:0006519) | 1.70738312 |
| 152 | Small intestinal stenosis (HP:0012848) | 1.70100163 |
| 153 | Duodenal stenosis (HP:0100867) | 1.70100163 |
| 154 | Polyneuropathy (HP:0001271) | 1.69573361 |
| 155 | Meckel diverticulum (HP:0002245) | 1.67455798 |
| 156 | Type I transferrin isoform profile (HP:0003642) | 1.67359667 |
| 157 | Viral hepatitis (HP:0006562) | 1.66716979 |
| 158 | Facial diplegia (HP:0001349) | 1.66694109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK3 | 4.42237896 |
| 2 | MAP4K1 | 3.75303696 |
| 3 | RIPK4 | 3.72966820 |
| 4 | TYK2 | 3.44978709 |
| 5 | MAP3K14 | 3.40441670 |
| 6 | EIF2AK1 | 3.34971416 |
| 7 | TRIM28 | 3.33690822 |
| 8 | KIT | 3.24213690 |
| 9 | JAK3 | 2.98983300 |
| 10 | * TBK1 | 2.94648483 |
| 11 | IKBKE | 2.75985171 |
| 12 | TXK | 2.69816646 |
| 13 | PBK | 2.54154216 |
| 14 | JAK1 | 2.38980316 |
| 15 | CSF1R | 2.19481970 |
| 16 | ERBB3 | 2.18274916 |
| 17 | BUB1 | 2.17625272 |
| 18 | NUAK1 | 2.10259680 |
| 19 | ZAP70 | 2.09530718 |
| 20 | IRAK4 | 2.09245717 |
| 21 | MAP3K13 | 2.00623854 |
| 22 | PDK2 | 1.98293665 |
| 23 | SYK | 1.95650906 |
| 24 | WEE1 | 1.86999252 |
| 25 | TEC | 1.86170781 |
| 26 | MAP2K3 | 1.83878503 |
| 27 | BCR | 1.77077606 |
| 28 | IKBKB | 1.76025697 |
| 29 | MAP4K2 | 1.73542907 |
| 30 | TAOK3 | 1.71997759 |
| 31 | PLK4 | 1.65894767 |
| 32 | BTK | 1.62925099 |
| 33 | FGFR4 | 1.62280685 |
| 34 | NEK1 | 1.60253107 |
| 35 | BMPR1B | 1.59576331 |
| 36 | FLT3 | 1.59254553 |
| 37 | BLK | 1.52617761 |
| 38 | IRAK3 | 1.49595768 |
| 39 | STK10 | 1.49259821 |
| 40 | LCK | 1.48371158 |
| 41 | TTK | 1.44534063 |
| 42 | ITK | 1.43214084 |
| 43 | FGFR3 | 1.43124646 |
| 44 | NEK9 | 1.35203652 |
| 45 | PLK3 | 1.29217738 |
| 46 | FRK | 1.27296865 |
| 47 | SRPK1 | 1.26542593 |
| 48 | EIF2AK2 | 1.25707963 |
| 49 | CHUK | 1.25226358 |
| 50 | HCK | 1.24012443 |
| 51 | SIK3 | 1.17021802 |
| 52 | GRK6 | 1.16221205 |
| 53 | LYN | 1.15402836 |
| 54 | JAK2 | 1.14929659 |
| 55 | ERN1 | 1.14653394 |
| 56 | MAP3K12 | 1.13609911 |
| 57 | PIM1 | 1.11056027 |
| 58 | TRPM7 | 1.10403333 |
| 59 | CLK1 | 1.07514224 |
| 60 | CSK | 1.07206744 |
| 61 | MATK | 1.06787207 |
| 62 | MKNK2 | 1.06579803 |
| 63 | TGFBR2 | 1.05235491 |
| 64 | STK38L | 1.01852410 |
| 65 | PIM2 | 0.99705221 |
| 66 | RIPK1 | 0.99370989 |
| 67 | FES | 0.95907123 |
| 68 | MST4 | 0.95089859 |
| 69 | BRD4 | 0.92760587 |
| 70 | DAPK1 | 0.89798718 |
| 71 | PKN2 | 0.88998872 |
| 72 | MAP3K6 | 0.84035197 |
| 73 | EEF2K | 0.83417202 |
| 74 | MKNK1 | 0.79805986 |
| 75 | MARK3 | 0.78071298 |
| 76 | STK4 | 0.76721663 |
| 77 | GRK7 | 0.75872987 |
| 78 | LRRK2 | 0.74463169 |
| 79 | CCNB1 | 0.74312252 |
| 80 | YES1 | 0.73674703 |
| 81 | ACVR1B | 0.73292960 |
| 82 | PAK4 | 0.73046009 |
| 83 | TNK2 | 0.69912441 |
| 84 | CDK6 | 0.68911697 |
| 85 | PTK6 | 0.68243876 |
| 86 | PLK1 | 0.64909454 |
| 87 | ERBB4 | 0.64743427 |
| 88 | SCYL2 | 0.62839036 |
| 89 | FGR | 0.62256947 |
| 90 | AKT3 | 0.61431750 |
| 91 | SGK3 | 0.60932971 |
| 92 | STK3 | 0.60557222 |
| 93 | EGFR | 0.60097525 |
| 94 | MST1R | 0.59984206 |
| 95 | ADRBK2 | 0.59304121 |
| 96 | FER | 0.59077382 |
| 97 | ZAK | 0.58604630 |
| 98 | TSSK6 | 0.55598313 |
| 99 | MAP3K5 | 0.55241214 |
| 100 | OXSR1 | 0.53119557 |
| 101 | SIK2 | 0.52396858 |
| 102 | CDK8 | 0.52207241 |
| 103 | BRSK1 | 0.50449864 |
| 104 | PDK1 | 0.50336492 |
| 105 | CAMK1D | 0.49986509 |
| 106 | CAMKK2 | 0.49815672 |
| 107 | PRKCD | 0.49628160 |
| 108 | NEK6 | 0.49444065 |
| 109 | PIK3CG | 0.48883325 |
| 110 | RPS6KA4 | 0.48742207 |
| 111 | TGFBR1 | 0.47980461 |
| 112 | KSR1 | 0.47361153 |
| 113 | TTN | 0.45969956 |
| 114 | PRKCQ | 0.45958083 |
| 115 | CSNK1G3 | 0.44330365 |
| 116 | IGF1R | 0.44282919 |
| 117 | PLK2 | 0.42949540 |
| 118 | ABL1 | 0.42859601 |
| 119 | CSNK1A1L | 0.41436456 |
| 120 | BMX | 0.41319720 |
| 121 | PTK2B | 0.41030346 |
| 122 | CDK12 | 0.41029326 |
| 123 | MAPK11 | 0.40213947 |
| 124 | ATR | 0.39467042 |
| 125 | PRKG2 | 0.39384236 |
| 126 | PRKCH | 0.38041875 |
| 127 | CDK4 | 0.37689207 |
| 128 | DYRK3 | 0.37476053 |
| 129 | ATM | 0.37052953 |
| 130 | CSNK1G2 | 0.36258932 |
| 131 | CSNK1G1 | 0.36049992 |
| 132 | TAF1 | 0.36017739 |
| 133 | RPS6KB2 | 0.35489921 |
| 134 | BMPR2 | 0.35426653 |
| 135 | SGK2 | 0.34756803 |
| 136 | NME2 | 0.34598904 |
| 137 | KDR | 0.34115910 |
| 138 | RAF1 | 0.33530530 |
| 139 | IRAK1 | 0.32682626 |
| 140 | STK24 | 0.30484420 |
| 141 | FYN | 0.29310070 |
| 142 | MAPKAPK2 | 0.28010323 |
| 143 | CDC7 | 0.27993915 |
| 144 | BRSK2 | 0.27008767 |
| 145 | RET | 0.26696159 |
| 146 | MAP3K11 | 0.25844105 |
| 147 | MAP2K6 | 0.25288297 |
| 148 | MAPK4 | 0.24751287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.72455824 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.21336030 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.82603773 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.79724418 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.73738491 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.62581634 |
| 7 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.54984143 |
| 8 | * Measles_Homo sapiens_hsa05162 | 2.50999182 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.37068796 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.34380148 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.33413517 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.32461107 |
| 13 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.31407368 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30935015 |
| 15 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.27875188 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.11192492 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.06158465 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 2.05263112 |
| 19 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.03748971 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.00836558 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 2.00313154 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.99732096 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.93931145 |
| 24 | * Influenza A_Homo sapiens_hsa05164 | 1.92705566 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83467399 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81885751 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.68674977 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62469211 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.62222142 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.60829129 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60141982 |
| 32 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.55920376 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55212637 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55203167 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.54326069 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.50256596 |
| 37 | RNA transport_Homo sapiens_hsa03013 | 1.44894067 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.44821948 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 1.44438465 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.43768210 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43226199 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.37583787 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.36234919 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.34574665 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31605016 |
| 46 | Lysosome_Homo sapiens_hsa04142 | 1.29925805 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29893600 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29845878 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.28825457 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.28201223 |
| 51 | * Hepatitis B_Homo sapiens_hsa05161 | 1.27666604 |
| 52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26011633 |
| 53 | Homologous recombination_Homo sapiens_hsa03440 | 1.23073419 |
| 54 | Phagosome_Homo sapiens_hsa04145 | 1.22344816 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19798607 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18649316 |
| 57 | Cell cycle_Homo sapiens_hsa04110 | 1.17292759 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15855277 |
| 59 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.15310248 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.07810955 |
| 61 | * Hepatitis C_Homo sapiens_hsa05160 | 1.06657984 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.04696255 |
| 63 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03334128 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01999116 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.99784976 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.99445123 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99041679 |
| 68 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.95679311 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93337181 |
| 70 | RNA polymerase_Homo sapiens_hsa03020 | 0.91308657 |
| 71 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.90934121 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90227843 |
| 73 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.86207182 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86113026 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.85057776 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84068053 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83761078 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83398345 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.80025931 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79232177 |
| 81 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77441908 |
| 82 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76700869 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75371049 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.74878345 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72394498 |
| 86 | Spliceosome_Homo sapiens_hsa03040 | 0.71830964 |
| 87 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71711850 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71524458 |
| 89 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70843751 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69841396 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65510952 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63129616 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.61672372 |
| 94 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61135624 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60695405 |
| 96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.59998089 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59747235 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58499839 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58303319 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.57797907 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55052959 |
| 102 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54527659 |
| 103 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53606257 |
| 104 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52377691 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50660032 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50435416 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.48169520 |
| 108 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.45775102 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.45155479 |
| 110 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.44660700 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43735486 |
| 112 | Peroxisome_Homo sapiens_hsa04146 | 0.43197768 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42971031 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42237248 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41850264 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41487934 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39555626 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38487552 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36926459 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36199278 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33214393 |
| 122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33105743 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32433635 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.32054324 |
| 125 | ABC transporters_Homo sapiens_hsa02010 | 0.31977834 |
| 126 | Base excision repair_Homo sapiens_hsa03410 | 0.31951690 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31496906 |
| 128 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31476346 |
| 129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30085799 |
| 130 | DNA replication_Homo sapiens_hsa03030 | 0.29772049 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28912609 |
| 132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26608273 |
| 133 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26164238 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.24923850 |
| 135 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.23149622 |
| 136 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.22470955 |
| 137 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.20351270 |
| 138 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.18826828 |
| 139 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.18470664 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.17931295 |
| 141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.16970480 |
| 142 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.16753308 |

